Great week for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) institutional investors after losing 78% over the previous year

By Yahoo! Finance | Sep 26, 2024 at 07:12 AM EST

Understanding a stock's ownership structure and analyst forecasts can reveal investment opportunities. Marinus Pharmaceuticals, Inc. is primarily institution-owned, with hedge funds owning 23%. Top shareholders like Tang Capital Management and Sofinnova Investment hold significant stakes.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.